BSG and neoplasm: The identification of Excretion‐EVs as carriers of tumour‐suppressive proteins, such as H3.2 (H3C14), CD147 and LAMB1, highlights an underexplored mechanism of GCB resistance involving the active excretion of unwanted intracellular regulators via EV secretion.